Talk:Polyclonal antibodies

Wiki Education Foundation-supported course assignment
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Mmouz001. Peer reviewers: Mmouz001.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 06:54, 17 January 2022 (UTC)

This
This pafe needs to be sectioned.

I would like to see the inclusion of antigen ranges used for human vaccines.Johnmbillings (talk) 15:13, 16 February 2008 (UTC)


 * Wouldn't it make more sense for that information to be posted in the individual vaccine articles? WhatamIdoing (talk) 22:09, 16 February 2008 (UTC)

Copyvio?
The information added about adjuvants added here seems to have come from the following page: [http://dels.nas.edu/ilar_n/ilarjournal/37_3/37_3SelectedAdjuvants.shtml. Review of Selected Adjuvants used in Antibody Production]. While I am not sure it is an out and out copyvio (some of the words were changed), I think that this page may need a complete rewrite in order to eliminate any appearance of copyright infringement, therefore I have added the "rewrite" tag to the article for this reason.--DO11.10 19:47, 6 March 2007 (UTC)

Why is there an adjuvant section on this page in the first place....adjuvants have their own separate article. This section should be entirely deleted from the article! 209.94.63.5 (talk) 15:05, 19 February 2009 (UTC)

Getting to B class
There's lots of info here, but there are no references. This is the biggest reason that the article is "Start" instead of "B" class. WhatamIdoing (talk) 06:10, 23 January 2008 (UTC)

Rename
The article was renamed from polyclonal antibody to Novangelis (talk) 16:28, 2 April 2008 (UTC)
 * 1) Avoid an oxymoron (one antibody could not be polyclonal)
 * 2) Agree with monoclonal antibodies, which could be singular (and possibly should)

Production/Advantages
I added a basic outline to the "Production" section with hopes it would appeal to a more general audience. I felt that including a broad approach to the production would make the more detailed facts to follow easier to understand. I included a few references in my revision as well. Additionally, I added an "Advantages" section to highlight the production and practical benefits of polyclonal antibody use, which further differentiates them from monoclonal antibodies. Mmouz001 (talk) 23:30, 20 November 2016 (UTC)